Humacyte (HUMA) Cash from Investing Activities (QoQ) (2020 - 2026)
Humacyte (HUMA) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Humacyte |
183.21 Mn |
134.67 Mn |
-1.54 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-348.72% |
| Dec 31, 2025 |
20.41% |
| Sep 30, 2025 |
91.37% |
| Jun 30, 2025 |
-149.12% |
| Mar 31, 2025 |
-261.90% |
| Dec 31, 2024 |
93.25% |
| Sep 30, 2024 |
-407.61% |
| Jun 30, 2024 |
52.94% |
| Mar 31, 2024 |
-160.67% |
| Dec 31, 2023 |
69.57% |
| Sep 30, 2023 |
-130.39% |
| Jun 30, 2023 |
240.80% |
| Mar 31, 2023 |
-122.10% |
| Dec 31, 2022 |
2,570.14% |
| Sep 30, 2022 |
-57.46% |
| Jun 30, 2022 |
-509.09% |
| Mar 31, 2022 |
99.73% |
| Dec 31, 2021 |
-9,592.77% |
| Sep 30, 2021 |
-31.75% |
| Jun 30, 2021 |
-117.24% |
